Key result
Overexpressing the glucose transporter GLUT1 in PPARalpha-null mouse hearts corrected metabolic and functional defects during high workload challenge.
Why the study?
Does overexpressing GLUT1 improve contractile and metabolic reserve in PPARalpha-null hearts?
Population
Perfused hearts isolated from genetically modified mice (PPARalpha) that mimic the metabolic profile in…
Comparison
Overexpressing the insulin-independent glucose… vs PPARalpha(-/-) hearts without GLUT1 overexpression
Design
Preclinical
Authors
Loading...
Supports GLUT1 as metabolic target in hypertrophy models; leaves open clinical translation to human heart failure.
Does overexpressing GLUT1 improve contractile and metabolic reserve in PPARalpha-null hearts?
Enhancing myocardial glucose utilization via GLUT1 overexpression rescues contractile and metabolic reserve in PPARalpha-deficient hearts, suggesting a potential therapeutic strategy for pathological hypertrophy.
Luptak et al. (2005) studied Myocardial hypertrophy / PPARalpha deficiency. Overexpressing the insulin-independent glucose transporter GLUT1 vs. PPARalpha(-/-) hearts without GLUT1 overexpression was evaluated on Contractile function and high-energy phosphate metabolism during high workload challenge. Overexpressing the glucose transporter GLUT1 in PPARalpha-null mouse hearts corrected metabolic and functional defects during high workload challenge.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: